The allotment of shares for Zenith Drugs IPO is likely to be finalised on February 23, 2024. Around 50% of the issue is reserved for qualified institutional buyers and 35% for retail investors. The ...
Zenith Drugs IPO: What you need to know about the company? Zenith Drugs is a reputable pharmaceutical manufacturing unit with a diverse portfolio of formulations and a wide range of medicines. It is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results